Please use this identifier to cite or link to this item: http://elibrary.nnra.gov.ng/jspui/handle/123456789/1151
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIAEA-
dc.date.accessioned2023-09-12T11:17:03Z-
dc.date.available2023-09-12T11:17:03Z-
dc.date.issued2023-
dc.identifier.issn2077-6462-
dc.identifier.urihttp://elibrary.nnra.gov.ng/jspui/handle/123456789/1151-
dc.descriptionThe primary objective of this publication is to provide a baseline guide for preclinical evaluation of radiopharmaceuticals, as a general review of the requirements of a facility where such work is conducted, as well as insight into the various scientific activities that constitute this process. It also aims to provide the general principles and baseline preclinical study protocols to characterize the safety, efficacy and quality of research on radiopharmaceuticals under development.en_US
dc.language.isoenen_US
dc.publisherNNRA Libraryen_US
dc.relation.ispartofseriesIAEA Radioisotopes and Radiopharmaceuticals Series no. 8;-
dc.subjectRadiopharmaceuticals.en_US
dc.subjectRadiopharmaceuticals — Clinical trials.en_US
dc.subjectNuclear medicine.en_US
dc.subjectClinical medicine — Research.en_US
dc.titleGuidance for Preclinical Studies with Radiopharmaceuticalsen_US
dc.typeBooken_US
Appears in Collections:Human Health

Files in This Item:
File Description SizeFormat 
Guidance for preclinical Studies with Radiopharmaceuticals.pdf3.36 MBAdobe PDFView/Open


Items in e-Library are protected by copyright, with all rights reserved, unless otherwise indicated.